1. Systemic scleroderma. Clinical and pathophysiologic aspects;Krieg;J Am Acad Dermatol,1988
2. Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis;Kulozik;J Clin Invest,1990
3. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen – producing cells in systemic sclerosis fibroblasts;Jelaska;Arthritis Rheum,1996
4. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma);Buckingham;J Lab Clin Med,1978
5. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β;Xu;J Rheumatol,1991